Clinical Trials Browser

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT04755517 2025-01-13

HPV400

Carcinoma, Carcinoma in Situ, Uterine Cervical Dysplasia, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Adenocarcinoma in Situ

NCT06741150 2024-12-18

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

Phase NA Recruiting

18 enrolled

Gynecologic

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT02039388 2022-09-02

LUSTIC

Phase NA Completed

701 enrolled

Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Carcinoma, Ovarian Epithelial, Carcinoma in Situ, Neoplasms, Ovarian Neoplasms

NCT04823871 2022-09-02

EHUD

Phase NA Completed

406 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Carcinoma in Situ, Neoplasms, Ovarian Neoplasms

NCT03195218 2017-06-22

UH3

Phase NA Unknown

1,780 enrolled

Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Disease

NCT02397252 2016-08-17

CASSIS

Phase NA Completed

1,225 enrolled

Gynecologic

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT01924117 2013-08-16

HPV

Phase NA Completed

129 enrolled

Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Neoplasms, Papillomavirus Infections

Clinical Trials

NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer

HPV400

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

LUSTIC

EHUD

UH3

CASSIS

HPV